AI assistant
Sending…
Arbutus Biopharma Corp — Director's Dealing 2021
Nov 12, 2021
32357_dirs_2021-11-12_68c654c5-17eb-428d-b062-8bffb775f122.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Arbutus Biopharma Corp (ABUS)
CIK: 0001447028
Period of Report: 2021-11-09
Reporting Person: Tran Tram (Director)
More from Arbutus Biopharma Corp
Regulatory Filings
2026
Jun 5
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Regulatory Filings
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 14
Earnings Release
2026
Mar 23
Annual Report
2026
Mar 23
Regulatory Filings
2026
Mar 3
Legal Proceedings Report
2026
Feb 20